Core Insights - Lakeside Holding Limited has expanded its distribution capabilities in the pharmaceutical sector through new agreements with Hubei Kelun Pharmaceutical Trading Co., Ltd. [1][3] - The agreements will enable Hupan Pharmaceutical to distribute large-volume parenteral solutions and related medical products across healthcare institutions in China, effective from January 1, 2025, to December 31, 2025 [2][3]. - This move follows a recent agreement with Sichuan Huiyu Pharmaceutical Co., Ltd., indicating Lakeside's growing partnerships with major pharmaceutical companies [3][4]. Company Overview - Lakeside Holding Limited is a U.S.-based cross-border supply chain solution provider focused on the Asia-Pacific market, operating through subsidiaries such as American Bear Logistics and Hupan Pharmaceutical [4][6]. - The company aims to deliver tailored logistics solutions that encompass both general and specialized sectors, enhancing its pharmaceutical logistics and distribution capabilities within China [6]. Strategic Developments - The recent acquisition of Hupan Pharmaceutical has allowed Lakeside to broaden its service scope and strengthen its position in the pharmaceutical distribution sector [6]. - The agreements with Kelun Pharmaceutical are seen as a testament to Lakeside's ability to build trust and relationships with leading pharmaceutical companies, ensuring efficient delivery of critical medical products [4].
Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical